Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-Quinolinamine,3-fluoro-(9CI), also known as 3-Fluoroquinoline-5-amine, is a chemical compound with the molecular formula C9H7FN. It belongs to the quinoline family and is characterized by the presence of a fluorine atom at the 3-position of the quinoline ring. This unique structure and properties make it a promising candidate for various applications in the pharmaceutical and agrochemical industries.

155014-05-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 155014-05-4 Structure
  • Basic information

    1. Product Name: 5-Quinolinamine,3-fluoro-(9CI)
    2. Synonyms: 5-Quinolinamine,3-fluoro-(9CI);3-fluoroquinolin-5-amine;5-Quinolimine,3-fluoro-(9CI)
    3. CAS NO:155014-05-4
    4. Molecular Formula: C9H7FN2
    5. Molecular Weight: 162.1636832
    6. EINECS: N/A
    7. Product Categories: HALIDE
    8. Mol File: 155014-05-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 320.8°Cat760mmHg
    3. Flash Point: 147.8°C
    4. Appearance: /
    5. Density: 1.315g/cm3
    6. Vapor Pressure: 0.00031mmHg at 25°C
    7. Refractive Index: 1.676
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. PKA: 2.86±0.23(Predicted)
    11. CAS DataBase Reference: 5-Quinolinamine,3-fluoro-(9CI)(CAS DataBase Reference)
    12. NIST Chemistry Reference: 5-Quinolinamine,3-fluoro-(9CI)(155014-05-4)
    13. EPA Substance Registry System: 5-Quinolinamine,3-fluoro-(9CI)(155014-05-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 155014-05-4(Hazardous Substances Data)

155014-05-4 Usage

Uses

Used in Pharmaceutical Industry:
5-Quinolinamine,3-fluoro-(9CI) is used as a building block in the synthesis of novel drugs. Its unique structure and properties, including the presence of the fluorine atom, may impart specific biological activities that can be harnessed for the development of new therapeutic agents. It can be incorporated into the molecular design of potential drug candidates, enhancing their pharmacological properties and improving their efficacy in treating various diseases.
Used in Agrochemical Industry:
5-Quinolinamine,3-fluoro-(9CI) can also serve as a precursor for the development of new agrochemical products. Its unique structure and properties may be utilized in the synthesis of novel agrochemicals with improved performance and selectivity. The presence of the fluorine atom in its structure may contribute to the enhancement of the biological activity and stability of the resulting agrochemicals, making them more effective in controlling pests and diseases in agriculture.
In Chemical Research and Development:
5-Quinolinamine,3-fluoro-(9CI) is a valuable target for chemical research and development due to its unique structure and properties. The presence of the fluorine atom in its structure may impart specific properties that can be explored for the development of new chemical reactions and synthetic methodologies. Additionally, its potential applications in the pharmaceutical and agrochemical industries make it an attractive subject for further investigation and optimization of its synthesis and functionalization.

Check Digit Verification of cas no

The CAS Registry Mumber 155014-05-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,0,1 and 4 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 155014-05:
(8*1)+(7*5)+(6*5)+(5*0)+(4*1)+(3*4)+(2*0)+(1*5)=94
94 % 10 = 4
So 155014-05-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H7FN2/c10-6-4-7-8(11)2-1-3-9(7)12-5-6/h1-5H,11H2

155014-05-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-fluoroquinolin-5-amine

1.2 Other means of identification

Product number -
Other names 3-Fluoro-5-aminoquinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:155014-05-4 SDS

155014-05-4Relevant articles and documents

INHIBITORS OF JUN N-TERMINAL KINASE

-

Page/Page column 146, (2010/08/18)

The present disclosure provides inhibitors of c-Jun N-terminal kinases (JNK) having a structure according to the following formula (I): or a salt or solvate thereof, wherein ring A, Ca, Cb, Z, R5, W and Cy are defined herein. The disclosure further provides pharmaceutical compositions including the compounds of the present disclosure and methods of making and using the compounds and compositions of the present disclosure, e.g., in the treatment and prevention of various disorders, such as Alzheimer's disease.

The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonists

Childers, Wayne E.,Havran, Lisa M.,Asselin, Magda,Bicksler, James J.,Chong, Dan C.,Grosu, George T.,Shen, Zhongqi,Abou-Gharbia, Magid A.,Bach, Alvin C.,Harrison, Boyd L.,Kagan, Natasha,Kleintop, Teresa,Magolda, Ronald,Marathias, Vasilios,Robichaud, Albert J.,Sabb, Annmarie L.,Zhang, Mei-Yi,Andree, Terrance H.,Aschmies, Susan H.,Beyer, Chad,Comery, Thomas A.,Day, Mark,Grauer, Steven M.,Hughes, Zoe A.,Rosenzweig-Lipson, Sharon,Platt, Brian,Pulicicchio, Claudine,Smith, Deborah E.,Sukoff-Rizzo, Stacy J.,Sullivan, Kelly M.,Adedoyin, Adedayo,Huselton, Christine,Hirst, Warren D.

experimental part, p. 4066 - 4084 (2010/08/06)

As part of an effort to identify 5-HT1A antagonists that did not possess typical arylalkylamine or keto/amido-alkyl aryl piperazine scaffolds, prototype compound 10a was identified from earlier work in a combined 5-HT 1A antagonist/SSRI program. This quinolyl-piperazinyl piperidine analogue displayed potent, selective 5-HT1A antagonism but suffered from poor oxidative metabolic stability, resulting in low exposure following oral administration. SAR studies, driven primarily by in vitro liver microsomal stability assessment, identified compound 10b, which displayed improved oral bioavailability and lower intrinsic clearance. Further changes to the scaffold (e.g., 10r) resulted in a loss in potency. Compound 10b displayed cognitive enhancing effects in a number of animal models of learning and memory, enhanced the antidepressant-like effects of the SSRI fluoxetine, and reversed the sexual dysfunction induced by chronic fluoxetine treatment.

Dual stimulatory and inhibitory effects of fluorine-substitution on mutagenicity: An extension of the enamine epoxide theory for activation of the quinoline nucleus

Saeki, Ken-Ichi,Kawai, Hiroshi,Kawazoe, Yutaka,Hakura, Atsushi

, p. 646 - 650 (2007/10/03)

Nineteen mono- and di-fluorinated derivatives of quinoline, 1,7- phenanthroline, 1,10-phenanthroline, benzo-[h]quinoline, and benzo[f]quinoline were subjected to analysis of their structure-mutagenicity relationships. For this purpose, six new fluorinated derivatives were synthesized. The results support that the enamine epoxide structure of the pyridine moiety, as well as the bay-region epoxide structure, is responsible for mutagenicity. Formation of K-region epoxides might involve a detoxification process rather than mutagenic activation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 155014-05-4